Biopharma Co Vyome gets Rs 154 crore from investors

New Delhi: Vyome Therapeutics, a biopharmaceutical firm focused on developing dermatology products, has raised $22 million (about Rs 154 crore) in a fresh round of funding led by Mumbai based venture growth fund Iron Pillar to expand its team and further invest in research and development.

Existing investors Perceptive Advisors, Romulus Capital and Kalaari Capital also participated in this round. Part of the funds are being used for a secondary transaction, the company said without elaborating. Prior to this round, the company had raised about $30 million from Perceptive Advisors, Romulus Capital, Kalaari Capital, Sabre Partners India, Aarin Capital and Navam Capital.

Dermatological conditions are among the most common types of disorders globally and a majority of the market share is held by large pharmaceutical firms with established product lines. However, with the emergence of a number of startups which have proven clinical and commercial success along with d eep understanding of many dermatological conditions, there is a renewed investor interest in disruptive companies in this segment.

  • Related Posts

    • Pharma
    • July 14, 2025
    • 115 views
    Enrolment in third phase clinical trials for India’s first dengue vaccine nearly complete, says ICMR

    Following an announcement by the Indian Council of Medical Research (ICMR) and Panacea Biotec Limited to initiate third phase trials, about 8,000 of the targeted 10,000 participants have enrolled in…

    • Pharma
    • July 14, 2025
    • 112 views
    In Gurgaon, illegal hospital busted, quack arrested in raid

    Gurgaon: A team from the chief minister’s flying squad conducted a raid at a private hospital in Fazalwas village on Tuesday. According to police, Shivansh Hospital, located on the Tauru…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Enrolment in third phase clinical trials for India’s first dengue vaccine nearly complete, says ICMR

    Enrolment in third phase clinical trials for India’s first dengue vaccine nearly complete, says ICMR

    In Gurgaon, illegal hospital busted, quack arrested in raid

    In Gurgaon, illegal hospital busted, quack arrested in raid

    Customs delivers 25 containers of seized drugs to NAFDAC

    Customs delivers 25 containers of seized drugs to NAFDAC

    License Of Four Pharma Firms Cancelled For Illegal Drug Trade In Jammu & Kashmir

    License Of Four Pharma Firms Cancelled For Illegal Drug Trade In Jammu & Kashmir